荣昌生物：董事会审议通过《关于公司<2025年度总经理工作报告>的议案》等多项议案

Core Viewpoint - Rongchang Biopharmaceutical announced the approval of several key proposals during its 36th meeting of the second board of directors, including the 2025 General Manager's Work Report and the 2025 Annual Report [1] Group 1 - The company held its 36th meeting of the second board of directors on March 27 [1] - The meeting approved the proposal for the 2025 General Manager's Work Report [1] - The meeting also approved the proposal for the 2025 Board of Directors' Work Report [1] - Additionally, the company approved the full text and summary of the 2025 Annual Report [1]